These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19222696)

  • 1. The role of RhoC in growth and metastatic capacity of melanoma.
    Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
    J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
    Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
    Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of EphB6 expression in metastatic melanoma.
    Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
    Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
    Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
    Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of RHOC is associated with metastasis of gastric carcinomas.
    Kondo T; Sentani K; Oue N; Yoshida K; Nakayama H; Yasui W
    Pathobiology; 2004; 71(1):19-25. PubMed ID: 14555841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER3 is a determinant for poor prognosis in melanoma.
    Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
    Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
    Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
    Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study.
    de Giorgi V; Mavilia C; Massi D; Gozzini A; Aragona P; Tanini A; Sestini S; Paglierani M; Boddi V; Brandi ML; Lotti T
    Arch Dermatol; 2009 Jan; 145(1):30-6. PubMed ID: 19153340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
    Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
    Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
    Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
    J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
    Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells.
    Zhang H; Rosdahl I
    Int J Oncol; 2004 Feb; 24(2):331-5. PubMed ID: 14719109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for c-erbB-2 overexpression in cutaneous melanoma.
    Fink-Puches R; Pilarski P; Schmidbauer U; Kerl H; Soyer HP
    Anticancer Res; 2001; 21(4A):2793-5. PubMed ID: 11724356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.